Carlo
PeopleProgramsSpecialtiesInstitutionsPricing
Sign inJoin waitlistJoin the waitlist
Carlo

the ai that helps you match

Part of the Carlo family
© 2026 Carlo Finance, Inc.
PeopleProgramsSpecialtiesInstitutionsPricingMethodologyPrivacyTerms
Back to overview

Michigan State University Advanced Heart Failure and Transplant Cardiology

Fellowship · Grand Rapids, MI

Sponsored by Corewell Health – Grand Rapids/Michigan State University · Director Renzo Loyaga-Rendon

Research

Works by its people
158
Authors
8
First-author works
43
Citations
5,543
20112026

Topics

  • Mechanical Circulatory Support Devices 62
  • Transplantation: Methods and Outcomes 17
  • Pulmonary Hypertension Research and Treatments 14
  • Cardiomyopathy and Myosin Studies 11
  • Heart Failure Treatment and Management 5
  • Cardiac pacing and defibrillation studies 4
  • Cardiac Structural Anomalies and Repair 4
  • Cardiac Valve Diseases and Treatments 4
  • Cardiovascular Function and Risk Factors 4
  • Bladder and Urothelial Cancer Treatments 3
  • Cardiovascular and exercise physiology 3
  • Amyloidosis: Diagnosis, Treatment, Outcomes 2

Most cited

  1. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM.

    Circulation · 2025 · 62 citations · David Fermin

  2. Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial.

    JAMA cardiology · 2023 · 153 citations · David Fermin

  3. Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort.

    JACC. Heart failure · 2024 · 84 citations · David Fermin

  4. Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial.

    JACC. Cardiovascular imaging · 2025 · 41 citations · David Fermin

  5. Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial.

    Circulation. Cardiovascular imaging · 2024 · 41 citations · David Fermin

  6. Improved 2-year heart transplant survival with moderate hypothermic donor heart preservation in the GUARDIAN heart registry.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026 · 6 citations · Renzo Loyaga-Rendon

  7. HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support.

    Journal of cardiac failure · 2023 · 28 citations · Renzo Loyaga-Rendon

  8. Aortic valve disorders and left ventricular assist devices.

    Frontiers in cardiovascular medicine · 2023 · 24 citations · Renzo Loyaga-Rendon